M. Tian

A peptide derived from melanotransferrin delivers a protein-based interleukin 1 receptor antagonist across the BBB and ameliorates neuropathic pain in a preclinical model

T. Abraham, W. Jefferies, R. Gabathuler, 2018, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

Discovery of a Highly Conserved Peptide in the Iron Transporter Melanotransferrin that Traverses an Intact Blood Brain Barrier and Localizes in Neural Cells

T. Abraham, W. Jefferies, R. Gabathuler, 2021, Frontiers in Neuroscience.

Calorimetric Studies of Melanotransferrin (p97) and Its Interaction with Iron*

W. Jefferies, C. Haynes, A. Creagh, 2005, Journal of Biological Chemistry.

Dendritic Cells : A Lesser known Part of the Immune System

M. Tian, 2004 .

Using the TAP Component of the Antigen-Processing Machinery as a Molecular Adjuvant

W. Jefferies, J. Alimonti, G. Basha, 2005, PLoS pathogens.

Control of dendritic cell cross-presentation by the major histocompatibility complex class I cytoplasmic domain

Kaan E. Biron, W. Jefferies, J. Julien, 2003, Nature Immunology.

The Use of Peptide and Protein Vectors to Cross the Blood-Brain Barrier for the Delivery of Therapeutic Concentration of Biologics

R. Gabathuler, M. Tian, 2020 .

Anti-cancer Antibody Trastuzumab-Melanotransferrin Conjugate (BT2111) for the Treatment of Metastatic HER2+ Breast Cancer Tumors in the Brain: an In-Vivo Study

P. Lockman, R. Gabathuler, M. Nounou, 2016, Pharmaceutical Research.

A Nanomule Peptide Carrier Delivers siRNA Across the Intact Blood-Brain Barrier to Attenuate Ischemic Stroke

T. Abraham, W. Jefferies, I. Welch, 2021, Frontiers in Molecular Biosciences.

A Nanomule Peptide-siRNA Conjugate that Traverses the Intact Blood Brain Barrier and Attenuates Stroke

T. Abraham, W. Jefferies, I. Welch, 2019, bioRxiv.